The Patent Finder

Maintenance fees coming due

Regeneron Pharmaceuticals, Inc.

275 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Dec 2, 2026. Unpaid by Jun 2, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,043,996Genetically Modified Major Histocompatibility Complex Animals
In force
Fee due Dec 2, 2026
Lapses if unpaid Jun 2, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 2, 2026Jun 2, 2027High confidence
US 10,306,874Non-Human Animals Having a Humanized Lymphocyte-Activation Gene 3
In force
Fee due Dec 4, 2026
Lapses if unpaid Jun 4, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 4, 2026Jun 4, 2027High confidence
US 11,666,040Humanized Non-Human Animals with Restricted Immunoglobulin Heavy Chain Loci
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · Medium confidence
Regeneron Pharmaceuticals, Inc.In forceDec 6, 2026Jun 7, 2027Medium confidence
US 11,666,658Rifamycin Analogs and Antibody-Drug Conjugates Thereof
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 6, 2026Jun 7, 2027High confidence
US 11,667,701Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 6, 2026Jun 7, 2027High confidence
US 10,314,296Genetically Modified Major Histocompatibility Complex Mice
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 11, 2026Jun 11, 2027High confidence
US 10,314,904Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 11, 2026Jun 11, 2027High confidence
US 10,316,105ANTI-TIE2 Antibodies and Uses Thereof
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 11, 2026Jun 11, 2027High confidence
US 11,673,930Novel IL10 Agonists and Methods of Use Thereof
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · High confidence
Regeneron Pharmaceuticals, Inc.In forceDec 13, 2026Jun 14, 2027High confidence
US 11,673,967Stabilized Formulations Containing ANTI-PCSK9 Antibodies
In force
Fee due Dec 13, 2026
Lapses if unpaid Jun 14, 2027
 · Medium confidence
Regeneron Pharmaceuticals, Inc.In forceDec 13, 2026Jun 14, 2027Medium confidence
265 more maintenance fees coming due in the 12 months from Nov 18, 2026 · Pro
10 of 275 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited